The Washington Post
· Sep 3, 2025 10:00 AM EDT
Not market news
Small GLP-1 doses are latest longevity ‘craze.’ There’s scant evidence they work.
Internet companies are helping stoke enthusiasm for “microdosing†weight-loss drugs for wellness, mood and joint pain.
AI brief
Pulse reads the full article- What happened
- Why it matters
- What to watch
Sign in to get the AI brief. Pulse explains what happened, why it matters, what to watch and who's exposed. Free for members.
Sign in to read the brief

